Interventions against West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus: where are we?
ARBO-ZOONET is an international network financed by the European Commission's seventh framework program. The major goal of this initiative is capacity building for the control of emerging viral vector-borne zoonotic diseases, with a clear focus on West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus. To evaluate the status quo of control measures against these viruses, an ARBO-ZOONET meeting was held in Istanbul, Turkey, from 19 to 20 November 2009. The symposium consisted of three themes: (1) vaccines: new and existing ones; (2) antivirals: existing and new developments; and (3) antivector vaccines. In addition, a satellite workshop was held on epidemiology and diagnosis. The meeting brought together foremost international experts on the subjects from both within and without the ARBO-ZOONET consortium. This report highlights selected results from these presentations and major conclusions that emanated from the discussions held.
Kortekaas
Jeroen
J
Virology Division, Cluster of Mammalian Virology, Central Veterinary Institute of Wageningen University Research Centre, Lelystad, The Netherlands.
Ergönül
Onder
O
Moormann
Rob J M
RJ
D000998:Antiviral Agents / Q000627:therapeutic use*; D021821:Communicable Diseases, Emerging / Q000517:prevention & control; D004196:Disease Outbreaks / Q000517:prevention & control; D006479:Hemorrhagic Fever, Crimean / Q000517:prevention & control*; D006801:Humans; D021122:Protein Subunits; D012295:Rift Valley Fever / Q000517:prevention & control*; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*; D014901:West Nile Fever / Q000517:prevention & control*
D000998:Antiviral Agents; D021122:Protein Subunits; D014614:Vaccines, Synthetic; D014765:Viral Vaccines